03:57 AM EST, 11/25/2025 (MT Newswires) -- Thermo Fisher Scientific ( TMO ) said late Monday it priced an offering of 2.1 billion euros ($2.42 billion) of senior notes at 100% of par value.

The offering consists of 1 billion euros of floating rate senior notes due 2027 and 1.1 billion euros of 3.628% senior notes due 2035.

Net proceeds will be used for general corporate purposes, which may include acquisitions, debt repayments, working capital, capital expenditures, and share repurchases, the company said.

Closing of the offering is expected to occur on or about Dec. 1, subject to customary closing conditions.